title: Reduction of fat accumulation and lipid disorders by individualized light aerobic training in human immunodeficiency virus infected patients with lipodystrophy and/or dyslipidemia.
abstract: BACKGROUND
  The management of abdominal fat accumulation and metabolic disorders in HIV1-infected patients, by an aerobic training program, is considered.
  
  
  METHODS
  Seventeen lipodystrophic and 2 dyslipidemic (without body modification) adults were studied before and after 4 months of training. The training load was individualized on a ventilatory threshold basis, determined during a maximal exercise test on cycle ergometer. Total (TAT), Visceral (VAT) and Subcutaneous Adipose Tissue (SAT) were assessed by CT-scan. Total (TC) and High Density Lipoprotein (HDL-C) Cholesterol, Triglycerides (TG), lactate (La), insulin and glucose were measured after a 12-hour-overnight fast. LDL, TC/HDL, TG/HDL, HOMA-insulin resistance index and coronary heart disease (CHD) relative risk (RR(CHD)) were calculated.
  
  
  RESULTS
  Besides a significant improvement of aerobic fitness, trained patients exhibited a reduction in TAT (-12.8%, p < 0.001), specially at the visceral level (- 12%, p < 0.01) and in TC, TG and La (- 23%, - 43% and - 19% respectively, p < 0.01). HDL-C was increased (+ 6%, p < 0.01). All these effects were above changes that could be expected by a possible regression to the mean artefact. Both TC/HDL and TG/HDL were reduced (p < 0.01) and the estimated RR(CHD) decreased by approximately 13% (p < 0.01). No significant training effect was observed on the 9 available HOMAs. Significant correlations were found between changes in blood lipid values and baseline measures (r range - 0.55 to - 0.79, p < 0.05), indicating a larger improvement when baseline lipid parameters were higher.
  
  
  CONCLUSIONS
  Aerobic training reduced visceral fat, lipid disorders, basal blood lactate and CHD markers in HIV patients. Training effects were particularly important for patients with marked dyslipidemia.
authors.affiliation: UPRES EA 2991, Sports, Performance, Health Laboratory, Faculty of Sport Sciences, Montpellier, France. gilles.thoni@sc.univ-montp1.fr
authors.forename: G J
authors.initials: GJ
authors.lastname: Thöni
authors.forename: C
authors.initials: C
authors.lastname: Fedou
authors.forename: J F
authors.initials: JF
authors.lastname: Brun
authors.forename: J
authors.initials: J
authors.lastname: Fabre
authors.forename: E
authors.initials: E
authors.lastname: Renard
authors.forename: J
authors.initials: J
authors.lastname: Reynes
authors.forename: A
authors.initials: A
authors.lastname: Varray
authors.forename: J
authors.initials: J
authors.lastname: Mercier
mesh_terms: D000273:Adipose Tissue / Q000033:anatomy & histology*; D000328:Adult; D015703:Antigens, CD / Q000097:blood; D001786:Blood Glucose / Q000378:metabolism; D015704:CD4 Antigens / Q000097:blood; D002784:Cholesterol / Q000097:blood; D015444:Exercise / Q000502:physiology*; D005080:Exercise Test; D005081:Exercise Therapy; D005260:Female; D015658:HIV Infections / Q000097:blood / Q000150:complications* / Q000503:physiopathology*; D015497:HIV-1; D006801:Humans; D006949:Hyperlipidemias / Q000097:blood / Q000150:complications / Q000503:physiopathology*; D007328:Insulin / Q000097:blood; D008060:Lipodystrophy / Q000097:blood / Q000150:complications / Q000503:physiopathology*; D008075:Lipoproteins, HDL / Q000097:blood; D008297:Male; D014280:Triglycerides / Q000097:blood
chemical_list: D015703:Antigens, CD; D001786:Blood Glucose; D015704:CD4 Antigens; D007328:Insulin; D008075:Lipoproteins, HDL; D014280:Triglycerides; D002784:Cholesterol